Diagenode, A Hologic

At Diagenode, a Hologic company, our goal is to build epigenetics products with pride and the highest level of performance. Overview Diagenode, a Hologic company, is a leading global provider of complete solutions for epigenetics research, biological sample preparation, and diagnostics assays. based in Liege, Belgium and NJ, USA. It was acquired by Hologic in March 2021. The company has developed a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative Bioruptor® shearing and IP-Star® automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company's latest innovations include a unique, full automation system, the industry's most validated antibodies, the Megaruptor shearing system for long fragment generation in sequencing, and epigenetics assay services. ► EPIGENETICS RESEARCH : Epigenetics is playing a revolutionary role in life sciences research. Diagenode continually innovates solutions and provides the highest quality epigenetics tools available. ► MOLECULAR DIAGNOSTICS : Diagenode offers amplification and quantification methods for DNA targets of human infectious disease to meet the fast-paced growth of human disease diagnostics. We also provide guidance to diagnostics companies to develop epigenetics-based diagnostics. Our products are designed to make diagnostic assays simpler, faster, and of highest quality. Our kits are CE-marked and certified ISO 9001 and ISO 13485.